Central Alerting System
View Alert


Originator: National Patient Safety Alert - DHSC

Issue date: 18-Dec-2024 13:23:09

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • Integrated Care Boards
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Shortage of Pancreatic enzyme replacement therapy (PERT) - Additional actions

Broadcast content:

This alert contains actions which are in addition to those outlined in the National Patient Safety Alert (NatPSA/2024/007/DHSC) issued on 24th May 2024. 

There are limited supplies of pancreatic enzyme replacement therapies (PERT). 

Creon® 10,000 and 25,000 capsules remain in limited supply until 2026. 

Nutrizym® 22 capsules and Pancrex V® capsules and powder are intermittently available but are unable to fully cover the gap in supply

This  National Patient Safety Alert provides further background, clinical information and actions for providers.



Additional information: NHS England regions: please cascade this to community pharmacy.

Alert reference: NatPSA/2024/013/DHSC

Action underway deadline: 20-Dec-2024

Action complete deadline: 31-Jan-2025

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency